日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

HCV infection induces ubiquitin-dependent degradation of LATS1, inactivating the Hippo pathway and upregulating transcription of the CYR61 and CTGF genes

HCV感染诱导LATS1的泛素依赖性降解,使Hippo通路失活,并上调CYR61和CTGF基因的转录。

Septianastiti, Maria Alethea; Matsui, Chieko; Xu, Zihan; Puspitasari, Fransisca; Adyaksa, Dewa Nyoman Murti; Deng, Lin; Abe, Takayuki; Shoji, Ikuo

Hepatitis C virus NS3/4A protease cleaves SPG20, a key regulator of lipid droplet turnover, to promote lipid droplet formation.

丙型肝炎病毒 NS3/4A 蛋白酶可切割 SPG20(脂滴周转的关键调节因子),从而促进脂滴形成。

Matsui Chieko, Yuliandari Putu, Deng Lin, Abe Takayuki, Shoji Ikuo

A Quinoline Derivative HZ-6d Induces Antiviral Activity Against Hepatitis C Virus Via Apoptosis-Mediated Cytotoxicity

喹啉衍生物HZ-6d通过诱导细胞凋亡介导的细胞毒性发挥抗丙型肝炎病毒的活性

Suwardana, Gede Ngurah Rsi; Rhamadianti, Aulia Fitri; Abe, Takayuki; Deng, Lin; Matsui, Chieko; Yasui, Motohiro; Takeda, Norihiko; Yamada, Takahiro; Ueda, Masafumi; Shoji, Ikuo

Hepatitis C Virus NS5A Inhibits YAP1-HSC70 Interaction, Thereby Preventing YAP1 Degradation Via Chaperone-Mediated Autophagy.

丙型肝炎病毒 NS5A 抑制 YAP1-HSC70 相互作用,从而阻止 YAP1 通过分子伴侣介导的自噬降解。

Septianastiti Maria Alethea, Matsui Chieko, Xu Zihan, Puspitasari Fransisca, Deng Lin, Abe Takayuki, Shoji Ikuo

Cellular Release of Infectious Hepatitis C Virus Particles via Endosomal Pathways

通过内吞途径释放具有传染性的丙型肝炎病毒颗粒

Deng, Lin; Solichin, Muchamad Ridotu; Adyaksa, Dewa Nyoman Murti; Septianastiti, Maria Alethea; Fitri, Rhamadianti Aulia; Suwardan, Gede Ngurah Rsi; Matsui, Chieko; Abe, Takayuki; Shoji, Ikuo

Hepatitis C virus NS5A protein promotes the lysosomal degradation of diacylglycerol O-acyltransferase 1 (DGAT1) via endosomal microautophagy.

丙型肝炎病毒 NS5A 蛋白通过内体微自噬促进二酰甘油 O-酰基转移酶 1 (DGAT1) 的溶酶体降解

Yuliandari Putu, Matsui Chieko, Deng Lin, Abe Takayuki, Mori Hiroyuki, Taguwa Shuhei, Ono Chikako, Fukuhara Takasuke, Matsuura Yoshiharu, Shoji Ikuo

The Role of Chaperone-Mediated Autophagy in Hepatitis C Virus-Induced Pathogenesis

分子伴侣介导的自噬在丙型肝炎病毒诱导的发病机制中的作用

Matsui, Chieko; Yuliandari, Putu; Deng, Lin; Abe, Takayuki; Shoji, Ikuo

Activity of xanthine oxidase in plasma correlates with indices of insulin resistance and liver dysfunction in patients with type 2 diabetes mellitus and metabolic syndrome: A pilot exploratory study

血浆中黄嘌呤氧化酶活性与2型糖尿病合并代谢综合征患者的胰岛素抵抗和肝功能障碍指标相关:一项初步探索性研究

Sunagawa, Sumito; Shirakura, Takashi; Hokama, Noboru; Kozuka, Chisayo; Yonamine, Masato; Namba, Toyotaka; Morishima, Satoko; Nakachi, Sawako; Nishi, Yukiko; Ikema, Tomomi; Okamoto, Shiki; Matsui, Chieko; Hase, Naoki; Tamura, Mizuho; Shimabukuro, Michio; Masuzaki, Hiroaki

Febuxostat, a novel xanthine oxidoreductase inhibitor, improves hypertension and endothelial dysfunction in spontaneously hypertensive rats

非布司他是一种新型黄嘌呤氧化还原酶抑制剂,可改善自发性高血压大鼠的高血压和内皮功能障碍。

Shirakura, Takashi; Nomura, Johji; Matsui, Chieko; Kobayashi, Tsunefumi; Tamura, Mizuho; Masuzaki, Hiroaki

Xanthine oxidase inhibition by febuxostat attenuates experimental atherosclerosis in mice

非布司他通过抑制黄嘌呤氧化酶来减轻小鼠实验性动脉粥样硬化。

Nomura, Johji; Busso, Nathalie; Ives, Annette; Matsui, Chieko; Tsujimoto, Syunsuke; Shirakura, Takashi; Tamura, Mizuho; Kobayashi, Tsunefumi; So, Alexander; Yamanaka, Yoshihiro